LifeMD, Inc. (NASDAQ:LFMD – Free Report) – Analysts at B. Riley issued their Q1 2025 EPS estimates for LifeMD in a research report issued to clients and investors on Tuesday, March 11th.

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now. By Rebecca Robbins It’s easy to make a medical case for ...

ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

With Lilly’s recent launch of additional doses of Zepbound vials and reduced pricing of existing vial doses, the integration will provide LifeMD’s eligible on-label patients with streamlined ...

Last week, it partnered with drugmaker Eli Lilly to offer the weight loss drug Zepbound directly to self-paying patients.

Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60%Adjusted EBITDA increased 78% to $9.0 millionTelehealth adjusted EBITDA increased 396% to $5.9 million ...

Tuesday saw KeyBanc Capital Markets reaffirm its Overweight rating on LifeMD Inc (NASDAQ:LFMD) stock, maintaining a price target of $7.50. The investment firm’s confidence in the telehealth provider ...

LifeMD produced tremendous results in the fourth ... authorization processes and overall infrastructure at LifeMD. For Zepbound, we've seen an 18 percentage point increase in the approval rate ...

LifeMD produced tremendous results in the fourth ... private insurance coverage for branded GLP-1 medications, especially for Zepbound. We believe this is partly due to private payer and employer ...

The latest price target for LifeMD (NASDAQ:LFMD) was reported by HC Wainwright & Co. on March 12, 2025. The analyst firm set a price target for $14.00 expecting LFMD to rise to within 12 months (a ...